Back to MDGL
CITADEL ADVISORS LLC MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
11
Latest value
$50.5M
Q2 2026
Peak value
$237.6M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $237.6M |
| Q1 2026 | $58.8M |
| Q1 2026 | $19M |
| Q2 2026 | $212.9M |
| Q2 2026 | $46.7M |
| Q2 2026 | $59.5M |
| Q2 2026 | $50.5M |
| Q2 2026 | $212.9M |
| Q2 2026 | $46.7M |
| Q2 2026 | $59.5M |
| Q2 2026 | $50.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $50.5M | 94.0K | — | — |
| Q2 2026 | $59.5M | 110.8K | — | — |
| Q2 2026 | $46.7M | 86.9K | — | — |
| Q2 2026 | $212.9M | 396.4K | — | — |
| Q2 2026 | $50.5M | 94.0K | — | — |
| Q2 2026 | $59.5M | 110.8K | — | — |
| Q2 2026 | $46.7M | 86.9K | — | — |
| Q2 2026 | $212.9M | 396.4K | — | — |
| Q1 2026 | $19M | 36.3K | — | — |
| Q1 2026 | $58.8M | 112.4K | — | — |
| Q1 2026 | $237.6M | 453.8K | — | — |
Other funds holding MDGL
$728.8M
$719.5M
$319.1M
$283M
$283M
$211.8M
$138.5M